CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma

Pathology Research and Practice

Volumn 207, Issue 1, 2011, Pages 43-48

  Kai, Hiromichi ^a   Kadono, Takafumi ^a   Kakinuma, Takashi ^a   Tomita, Manabu ^a   Ohmatsu, Hanako ^a   Asano, Yoshihide ^a   Tada, Yayoi ^a   Sugaya, Makoto ^a   Sato, Shinichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

CCL27; CCR10; Squamous cell carcinoma

Indexed keywords

CHEMOKINE RECEPTOR CCR10; CUTANEOUS T CELL ATTRACTING CHEMOKINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SEBORRHEIC KERATOSIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

BIOPSY; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHEMOKINE CCL27; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; KERATOSIS, ACTINIC; KERATOSIS, SEBORRHEIC; RECEPTORS, CCR10; SKIN; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650231700     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.10.007     Document Type: Article

References (18)

1. Basile J., Thiers B., Maize J., Lathers D.M. Chemokine receptor expression in non-melanoma skin cancer. J. Cutan. Pathol. 2008, 35:623-629.
2. Brenn T., McKee Q.H. Tumors of the surface epithelium. Pathology of the Skin 2005, 1204. Elsevier, Amsterdam. third ed. Q.H. McKee, E. Calonje, S.R. Granter (Eds.).
3. Chuang T.Y., Reizner G.T., Elpern D.J., Stone J.L., Farmer E.R. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report. J. Am. Acad. Dermatol. 1995, 33:422-426.
4. Faaij C.M., Lankester A.C., Spierings E., Hoogeboom M., Bowman E.P., Bierings M., Revesz T., Egeler R.M., van Tol M.J., Annels N.E. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease. Br. J. Haematol. 2006, 133:538-549.
5. Gabellini C., Trisciuoglio D., Desideri M., Candiloro A., Ragazzoni Y., Orlandi A., Zupi G., Del Bufalo D. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur. J. Cancer 2009, 45:2618-2627.
6. Gasser O., Missiou A., Eken C., Hess C. Human CD8+ T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation. Blood 2005, 106:3718-3724.
7. Gloster H.M., Neal K. Skin cancer in skin of color. J. Am. Acad. Dermatol. 2006, 55:741-760. quiz 761-744.
8. Homey B., Alenius H., Muller A., Soto H., Bowman E.P., Yuan W., McEvoy L., Lauerma A.I., Assmann T., Bunemann E., Lehto M., Wolff H., Yen D., Marxhausen H., To W., Sedgwick J., Ruzicka T., Lehmann P., Zlotnik A. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 2002, 8:157-165.
9. Ishihara K., Saida T., Otsuka F., Yamazaki N. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int. J. Clin. Oncol. 2008, 13:33-41.
10. Kagami S., Saeki H., Komine M., Kakinuma T., Nakamura K., Tsunemi Y., Sasaki K., Asahina A., Tamaki K. CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27. Exp. Dermatol. 2006, 15:95-100.
11. Kakinuma T., Hwang S.T. Chemokines, chemokine receptors, and cancer metastasis. J. Leukoc. Biol. 2006, 79:639-651.
12. Kakinuma T., Saeki H., Tsunemi Y., Fujita H., Asano N., Mitsui H., Tada Y., Wakugawa M., Watanabe T., Torii H., Komine M., Asahina A., Nakamura K., Tamaki K. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J. Allergy Clin. Immunol. 2003, 111:592-597.
13. Koh D., Wang H., Lee J., Chia K.S., Lee H.P., Goh C.L. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. Br. J. Dermatol. 2003, 148:1161-1166.
14. Murakami T., Cardones A.R., Finkelstein S.E., Restifo N.P., Klaunberg B.A., Nestle F.O., Castillo S.S., Dennis P.A., Hwang S.T. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J. Exp. Med. 2003, 198:1337-1347.
15. Notohamiprodjo M., Segerer S., Huss R., Hildebrandt B., Soler D., Djafarzadeh R., Buck W., Nelson P.J., von Luettichau I. CCR10 is expressed in cutaneous T-cell lymphoma. Int. J. Cancer 2005, 115:641-647.
16. Pivarcsi A., Muller A., Hippe A., Rieker J., van Lierop A., Steinhoff M., Seeliger S., Kubitza R., Pippirs U., Meller S., Gerber P.A., Liersch R., Buenemann E., Sonkoly E., Wiesner U., Hoffmann T.K., Schneider L., Piekorz R., Enderlein E., Reifenberger J., Rohr U.P., Haas R., Boukamp P., Haase I., Nurnberg B., Ruzicka T., Zlotnik A., Homey B. Tumor immune escape by the loss of homeostatic chemokine expression. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19055-19060.
17. Simonetti O., Goteri G., Lucarini G., Filosa A., Pieramici T., Rubini C., Biagini G., Offidani A. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape. Eur. J. Cancer 2006, 42:1181-1187.
18. Ueda A., Suda K., Matsumoto T., Uekusa T., Sasahara N. A clinicopathological and immunohistochemical comparison of squamous cell carcinoma arising in scars versus nonscar SCC in Japanese patients. Am. J. Dermatopathol. 2006, 28:472-477.